Genpact Limited (NYSE:G) Stock Holdings Increased by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP boosted its position in Genpact Limited (NYSE:G - Free Report) by 18.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,671 shares of the business services provider's stock after purchasing an additional 27,044 shares during the period. ExodusPoint Capital Management LP owned about 0.10% of Genpact worth $7,631,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of G. SRH Advisors LLC acquired a new stake in Genpact during the 4th quarter valued at $26,000. Manchester Capital Management LLC purchased a new stake in Genpact during the 4th quarter worth about $38,000. Smartleaf Asset Management LLC raised its stake in Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares during the last quarter. UMB Bank n.a. lifted its holdings in Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp grew its holdings in shares of Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock worth $69,000 after buying an additional 453 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Stock Down 3.9 %

NYSE G traded down $1.89 on Thursday, hitting $46.23. 315,920 shares of the stock traded hands, compared to its average volume of 1,350,800. The company has a market capitalization of $8.12 billion, a P/E ratio of 16.32, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. The stock has a 50-day moving average of $51.09 and a 200 day moving average of $45.67. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date was Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is 23.94%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and boosted their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, Mizuho lifted their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of "Hold" and a consensus price target of $48.44.

Insider Transactions at Genpact

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.